It's the latest in a growing wave of bets that AI companies are making on brain data. OpenAI's venture capital arm as well as Peter Thiel's Founders Fund are investing in Coherence Neuro, a startup developing a brain implant to detect and treat cancer . The investments are part of a $45 million seed funding round for Coherence and reflect Big Tech's burgeoning interest in brain data . Coherence's CEO and cofounder Ben Woodington says there is "growing synergy" between the big AI labs and companies building devices to decode the brain, known as brain-computer interfaces . "The idea of capturing data to train better models and use it to optimize treatments is going to be super important," he says.

Bridge Neurotech is planning to build a wearable brain-computer interface that uses ultrasound. Sam Altman-backed Merge Labs has a new competitor in the race to build a brain-computer interface powered by ultrasound. Bridge Neurotech is launching with $13.5 million in funding, including from venture firm General Catalyst, which has also backed major tech companies such as Anduril, Anthropic, Airbnb, and Stripe. The company is the latest in a growing field of startups that aim to translate signals from the brain into useful actions. Elon Musk's Neuralink, plus Synchron, Paradromics, and Precision Neuroscience are all working on brain-computer interfaces to help people who have lost the ability to move or speak.

Gestala is the latest company to emerge from China's burgeoning brain-computer interface industry. It plans to access the brain with noninvasive ultrasound technology. China's brain-computer interface industry is growing fast, and the newest company to emerge from the country is aiming to access the brain without the use of invasive implants . Gestala, newly founded in Chengdu with offices in Shanghai and Hong Kong, plans to use ultrasound technology to stimulate--and eventually read from--the brain, according to CEO and cofounder Phoenix Peng. It's the second company to launch in recent weeks with the aim of tapping into the brain with ultrasound.

Merge Labs has emerged from stealth with $252 million in funding from OpenAI and others. It aims to use ultrasound to read from and write to the brain. On Thursday, OpenAI announced its investment in neurotech startup Merge Labs, cofounded by its CEO, billionaire Sam Altman . OpenAI will collaborate with the new venture to develop technology to link people's brains to computers. Merge Labs has raised $252 million in funding from OpenAI, private investment firm Bain Capital, video game developer Gabe Newell, and others to use ultrasound to read and modulate the brain.

An AI model that learns without human input--by posing interesting queries for itself--might point the way to superintelligence. Even the smartest artificial intelligence models are essentially copycats. They learn either by consuming examples of human work or by trying to solve problems that have been set for them by human instructors. But perhaps AI can, in fact, learn in a more human way--by figuring out interesting questions to ask itself and attempting to find the right answer. A project from Tsinghua University, the Beijing Institute for General Artificial Intelligence (BIGAI), and Pennsylvania State University shows that AI can learn to reason in this way by playing with computer code.

More accurate and individualized health predictions will allow for preventative factors to be implemented well in advance. In 2026, we will see the beginning of precision medical forecasting. Just as there have been remarkable advances in weather forecasting with the use of large language models, so will there be for determining an individual's risk of the major age-related diseases (cancer, cardiovascular, and neurodegenerative). These diseases share common threads, such as a long incubation phase before any symptoms are manifest, usually two decades or more. They also have the same biologic underpinnings of immunosenescence and inflammaging, terms that characterize an immune system that has lost some of its functionality and protective power, and the accompanying heightened inflammation.

Merge Labs, a brain-computer interface startup that seeks to read brain activity using ultrasound, is being spun out of Forest Neurotech, a Los Angeles nonprofit. Samuel Altman, CEO of OpenAI, testifies in Washington, DC, on May 16, 2023. OpenAI CEO Sam Altman's new brain-computer interface startup, Merge Labs, is being spun out of the Los Angeles-based nonprofit Forest Neurotech, according to a source with direct knowledge of the plans. It will focus on using ultrasound to read brain activity. Along with Altman, WIRED has learned, Forest Neurotech's CEO Sumner Norman and chief scientific officer Tyson Aflalo are among the cofounders of Merge Labs, which is still in stealth mode.

The tussles between billionaires have seen vast fortunes splashed on everything from rocket ships to social media empires. But now, two titans of big tech are taking their fight to a frontier: The race to link our brains with AI. Tesla and xAI CEO Elon Musk and Sam Altman of OpenAI, the company behind ChatGPT, are vying to be the first to connect mind and machine. The former allies are now both backing rival companies trying to build brain-computer-interface (BCI) chips and put them inside humans. These devices allow people to directly control computers with their thoughts by reading the electrical signals produced in the brain. As outspoken champions of the technology, both Mr Musk and Mr Altman claim that BCIs will one day allow humanity to merge with artificial intelligence.